| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |